Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)
22.03
+0.25 (1.15%)
Sep 18, 2026, 3:00 PM CST
Shanghai Fosun Pharmaceutical (Group) Employees
Shanghai Fosun Pharmaceutical (Group) had 40,684 employees as of June 30, 2026. The number of employees increased by 81 or 0.20% since the number was reported on December 31, 2025.
Employees
40,684
Change
81
Growth
0.20%
Revenue / Employee
1.05M CNY
Profits / Employee
83.33K CNY
Market Cap
54.24B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 40,684 | 81 | 0.20% |
| Dec 31, 2025 | 40,603 | 46 | 0.11% |
| Dec 31, 2024 | 40,557 | 187 | 0.46% |
| Dec 31, 2023 | 40,370 | 1,971 | 5.13% |
| Dec 31, 2022 | 38,399 | 2,120 | 5.84% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| China Resources Sanjiu Medical & Pharmaceutical | 30,304 |
| Huadong Medicine | 19,095 |
| Beijing Tongrentang | 17,284 |
| Humanwell Healthcare (Group) | 17,153 |
| Zhejiang NHU Company | 11,508 |
| Changchun High-Tech Industry (Group) | 10,080 |
| Yunnan Baiyao Group Co.,Ltd | 9,286 |
| Dong-E-E-Jiao | 4,345 |
Shanghai Fosun Pharmaceutical (Group) News
- 13 days ago - Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion - PRNewsWire
- 25 days ago - Fosun Pharma Announces 2026 Interim Results - PRNewsWire
- 26 days ago - Shanghai Fosun Pharmaceutical (Group) Quarterly report: Q2 2026 - Filings
- 4 months ago - Shanghai Fosun Pharmaceutical (Group) Quarterly report: Q1 2026 - Filings
- 5 months ago - Global pharma companies that have publicly announced Trump drug pricing agreements - Reuters
- 6 months ago - Shanghai Fosun Pharmaceutical (Group) Annual report: H2 2025 - Filings
- 6 months ago - Shanghai Fosun Pharmaceutical (Group) Slides: H2 2025 - Filings
- 10 months ago - Shanghai Fosun Pharmaceutical (Group) Quarterly report: Q3 2025 - Filings